Literature DB >> 24102389

New insights into the molecular mechanism of intestinal fatty acid absorption.

Tony Y Wang1, Min Liu, Piero Portincasa, David Q-H Wang.   

Abstract

BACKGROUND: Dietary fat is one of the most important energy sources of all the nutrients. Fatty acids, stored as triacylglycerols (also called triglycerides) in the body, are an important reservoir of stored energy and derived primarily from animal fats and vegetable oils.
DESIGN: Although the molecular mechanisms for the transport of water-insoluble amphipathic fatty acids across cell membranes have been debated for many years, it is now believed that the dominant means for intestinal fatty acid uptake is via membrane-associated fatty acid-binding proteins, that is, fatty acid transporters on the apical membrane of enterocytes.
RESULTS: These findings indicate that intestinal fatty acid absorption is a multistep process that is regulated by multiple genes at the enterocyte level, and intestinal fatty acid absorption efficiency could be determined by factors influencing intraluminal fatty acid molecules across the brush border membrane of enterocytes. To facilitate research on intestinal, hepatic and plasma triacylglycerol metabolism, it is imperative to establish standard protocols for precisely and accurately measuring the efficiency of intestinal fatty acid absorption in humans and animal models. In this review, we will discuss the chemical structure and nomenclature of fatty acids and summarize recent progress in investigating the molecular mechanisms underlying the intestinal absorption of fatty acids, with a particular emphasis on the physical chemistry of intestinal lipids and the molecular physiology of intestinal fatty acid transporters.
CONCLUSIONS: A better understanding of the molecular mechanism of intestinal fatty acid absorption should lead to novel approaches to the treatment and the prevention of fatty acid-related metabolic diseases that are prevalent worldwide.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Bile acids; cholesterol absorption; chylomicrons; hypolipidaemic drugs; intestinal fatty acid transporter; pancreatic lipase

Mesh:

Substances:

Year:  2013        PMID: 24102389      PMCID: PMC3996833          DOI: 10.1111/eci.12161

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  107 in total

Review 1.  A proposed model for the assembly of chylomicrons.

Authors:  M M Hussain
Journal:  Atherosclerosis       Date:  2000-01       Impact factor: 5.162

2.  Incorporation of dietary lecithin and lysolecithin into lymph chylomicrons in the rat.

Authors:  R O Scow; Y Stein; O Stein
Journal:  J Biol Chem       Date:  1967-11-10       Impact factor: 5.157

3.  Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.

Authors:  M van Heek; C Farley; D S Compton; L Hoos; H R Davis
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

4.  In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461.

Authors:  M Van Heek; C F France; D S Compton; R L McLeod; N P Yumibe; K B Alton; E J Sybertz; H R Davis
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

5.  Factors regulating the formation of chylomicrons and very-low-density lipoproteins by the rat small intestine.

Authors:  P Tso; M B Lindström; B Borgström
Journal:  Biochim Biophys Acta       Date:  1987-12-14

6.  Intestinal absorption and lymphatic transport of cholesterol in the rat: influence of the fatty acid chain length of the carrier triglyceride.

Authors:  C Sylvén; B Borgström
Journal:  J Lipid Res       Date:  1969-07       Impact factor: 5.922

7.  Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.

Authors:  Eric D Labonté; Lisa M Camarota; Juan C Rojas; Ronald J Jandacek; Dean E Gilham; Joanna P Davies; Yiannis A Ioannou; Patrick Tso; David Y Hui; Philip N Howles
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

8.  Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.

Authors:  Mark A Valasek; Joyce J Repa; Gang Quan; John M Dietschy; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

9.  CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine.

Authors:  Fatiha Nassir; Brody Wilson; Xianlin Han; Richard W Gross; Nada A Abumrad
Journal:  J Biol Chem       Date:  2007-05-15       Impact factor: 5.157

10.  Administration of phosphatidylcholine-cholesterol liposomes partially reconstitutes fat absorption in chronically bile-diverted rats.

Authors:  Tomoji Nishioka; Rick Having; Susumu Tazuma; Frans Stellaard; Folkert Kuipers; Henkjan J Verkade
Journal:  Biochim Biophys Acta       Date:  2004-03-22
View more
  56 in total

1.  Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion.

Authors:  Frits Mattijssen; Sheril Alex; Hans J Swarts; Albert K Groen; Evert M van Schothorst; Sander Kersten
Journal:  Mol Metab       Date:  2013-11-20       Impact factor: 7.422

Review 2.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

3.  Titanium Dioxide Nanoparticle Ingestion Alters Nutrient Absorption in an In Vitro Model of the Small Intestine.

Authors:  Zhongyuan Guo; Nicole J Martucci; Fabiola Moreno-Olivas; Elad Tako; Gretchen J Mahler
Journal:  NanoImpact       Date:  2017-01-18

4.  Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.

Authors:  Emma Lawless; Brendan T Griffin; Aoife O'Mahony; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-11-27       Impact factor: 4.200

5.  Ontogenesis and Modulation of Intestinal Unesterified Cholesterol Sequestration in a Mouse Model of Niemann-Pick C1 Disease.

Authors:  Adam M Lopez; Charina M Ramirez; Anna M Taylor; Ryan D Jones; Joyce J Repa; Stephen D Turley
Journal:  Dig Dis Sci       Date:  2019-07-17       Impact factor: 3.199

6.  Discovery of Natural Product Derived Labdane Appended Triazoles as Potent Pancreatic Lipase Inhibitors.

Authors:  Renjitha Jalaja; Shyni G Leela; Praveen K Valmiki; Chettiyan Thodi F Salfeena; Kizhakkan T Ashitha; Venkata Rao D Krishna Rao; Mangalam S Nair; Raghu K Gopalan; Sasidhar B Somappa
Journal:  ACS Med Chem Lett       Date:  2018-06-18       Impact factor: 4.345

7.  Characterizing the Natural History of Acute Radiation Syndrome of the Gastrointestinal Tract: Combining High Mass and Spatial Resolution Using MALDI-FTICR-MSI.

Authors:  Claire L Carter; Kim G Hankey; Catherine Booth; Gregory L Tudor; George A Parker; Jace W Jones; Ann M Farese; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2019-04       Impact factor: 1.316

8.  Apolipoprotein A-V is present in bile and its secretion increases with lipid absorption in Sprague-Dawley rats.

Authors:  Linda S Zhang; Hirokazu Sato; Qing Yang; Robert O Ryan; David Q-H Wang; Philip N Howles; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-01       Impact factor: 4.052

9.  Prognostic value of prealbumin, N-terminal pro-B-type natriuretic peptide, heart type fatty acid binding protein, and cardiac troponin I in elderly patients for heart failure and poor outcomes.

Authors:  Shengzhuo Wang; Ketong Liu; Shoukun Guan; Ge Cui
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

10.  The Drosophila E78 nuclear receptor regulates dietary triglyceride uptake and systemic lipid levels.

Authors:  Sophia A Praggastis; Geanette Lam; Michael A Horner; Hyuck-Jin Nam; Carl S Thummel
Journal:  Dev Dyn       Date:  2021-01-09       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.